Bailard, Inc. Harrow Health, Inc. Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$10.28 - $14.78 $115,516 - $166,082	11,237 New	11,237 $165,000
Q2 2022 Jul 27, 2022	BUY	$5.75 - $7.74 $8,711 - $11,726	1,515 Added 9.89%	16,837 $123,000
Q1 2022 Apr 25, 2022	BUY	$6.77 - $8.66 $103,729 - $132,688	15,322 New	15,322 $104,000

176

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.